title: Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
abstract: Purified Vero cell rabies vaccine was used to treat 19 patients who experienced fox bite. Seventeen patients survived, and 2 patients died of rabies. Maximum antibody titers determined using a rapid fluorescent focus inhibition test were 25 IU, < or =90 days after the first vaccination and were 30 IU on day 1050 after booster vaccination.
authors.affiliation: District Hospital, Nashik, India. indhu-matha@yahoo.com
authors.forename: I S
authors.initials: IS
authors.lastname: Matha
authors.forename: S R
authors.initials: SR
authors.lastname: Salunke
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001733:Bites and Stings; D002648:Child; D002522:Chlorocebus aethiops; D005260:Female; D005589:Foxes; D006801:Humans; D007117:Immunization, Secondary; D007194:India; D008297:Male; D008875:Middle Aged; D011818:Rabies / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use*; D011820:Rabies virus / Q000276:immunology*; D016896:Treatment Outcome; D014611:Vaccination; D014709:Vero Cells
chemical_list: D000914:Antibodies, Viral; D011819:Rabies Vaccines